Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 39

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 39
---
 the future.                                                                                                                                 |

<div align='center'>19</div>

| ● | NewGenIvf’s future revenue may not grow at the rates it historically has, or at all.                                                                                                                  |
| ● | NewGenIvf’s quarterly and annual results may fluctuate significantly and may not fully reflect the underlying performance of NewGenIvf’s business.                                                    |
| ● | If the estimates and assumptions NewGenIvf uses to determine the size of the target markets for its services are inaccurate, its future growth rate may be impacted and its business would be harmed. |
| ● | NewGenIvf may not be able to successfully manage its growth, and if NewGenIvf is not able to grow efficiently, its business, financial condition and results of operations could be harmed.           |

| ● | If NewGenIvf’s new solutions and services are not adopted by its clients, or if it fails to innovate and develop new offerings that are adopted by its clients, its revenue and results of operations may be adversely affected.         |
| ● | If NewGenIvf fails to adapt and respond effectively to the changing medical landscape, changing regulations, changing client needs, requirements or preferences, its offerings may become less competitive.                              |
| ● | If NewGenIvf fails to maintain and enhance its brand, its ability to expand its client base will be impaired and its business, financial condition and results of operations may suffer.                                                 |
| ● | If NewGenIvf fails to retain and motivate members of its management team or other key employees, or fails to attract additional qualified personnel to support its operations, its business and future growth prospects could be harmed. |
| ● | To successfully market and sell its services and products in Asia-Pacific markets, NewGenIvf must address many international business risks with which NewGenIvf has limited experience.                                                 |

| ● | Ethical, legal and social concerns related to the use of assisted reproductive technology could reduce demand for the fertility services provided by the medical facilities in NewGenIvf’s network, and thus may adversely affect the business, financial conditions and results of operations of the medical facilities in its network. |
| ● | NewGenIvf is reliant on revenue from international clients.                                                                                                                                                                                                                                                                              |
| ● | Fluctuations in exchange rates could have a material and adverse effect on NewGenIvf’s results of operations and the value of your investment.                                                                                                                                                                                           |

| ● | Governmental control of currency conversion may limit NewGenIvf’s ability to utilize